|

Inqovi Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ASTX727, Decitabine and Cedazuridine

Pipeline

Early 1: 1

Top Sponsors

  • Lachelle D. Weeks, MD, PhD1

Indications

  • Clonal Cytopenia of Undetermined Significance1
  • Cytopenia1
  • Cancer1

Boston, Massachusetts1 trial

Early Intervention in High Risk CCUS

Dana-Farber Cancer Institute

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.